These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31174013)

  • 1. Structural bioinformatics analysis of variants on GPCR function.
    Syed Haneef SA; Ranganathan S
    Curr Opin Struct Biol; 2019 Apr; 55():161-177. PubMed ID: 31174013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding.
    Ahn KH; Scott CE; Abrol R; Goddard WA; Kendall DA
    Proteins; 2013 Aug; 81(8):1304-17. PubMed ID: 23408552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Insights into CB1 Receptor Biased Signaling.
    Al-Zoubi R; Morales P; Reggio PH
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determinants of GPCR pharmacogenetics: Deconstructing the population variants in β
    Joshi M; Nikte SV; Sengupta D
    Adv Protein Chem Struct Biol; 2022; 128():361-396. PubMed ID: 35034724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-Assisted Protein Structure (LAPS): An Experimental Paradigm for Characterizing Cannabinoid-Receptor Ligand-Binding Domains.
    Janero DR; Korde A; Makriyannis A
    Methods Enzymol; 2017; 593():217-235. PubMed ID: 28750804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1.
    Fay JF; Farrens DL
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8469-74. PubMed ID: 26100912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of the G protein-coupled receptors.
    Thompson MD; Cole DE; Capra V; Siminovitch KA; Rovati GE; Burnham WM; Rana BK
    Methods Mol Biol; 2014; 1175():189-242. PubMed ID: 25150871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of structurally and functionally high-risk nsSNPs impacts on human bone morphogenetic protein receptor type IA (BMPR1A) by computational approach.
    Islam MJ; Parves MR; Mahmud S; Tithi FA; Reza MA
    Comput Biol Chem; 2019 Jun; 80():31-45. PubMed ID: 30884445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights and functional implications of inter-individual variability in β2-adrenergic receptor.
    Tandale A; Joshi M; Sengupta D
    Sci Rep; 2016 Apr; 6():24379. PubMed ID: 27075228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational analysis of the CB1 carboxyl-terminus in the receptor-G protein complex.
    Shim JY; Khurana L; Kendall DA
    Proteins; 2016 Apr; 84(4):532-43. PubMed ID: 26994549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing clinically relevant natural variants of GPCRs using computational approaches.
    Sengupta D; Sonar K; Joshi M
    Methods Cell Biol; 2017; 142():187-204. PubMed ID: 28964336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of cannabinoid receptors.
    Abood ME
    Handb Exp Pharmacol; 2005; (168):81-115. PubMed ID: 16596772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of rhodopsin studies for GPCR activation.
    Deupi X
    Biochim Biophys Acta; 2014 May; 1837(5):674-82. PubMed ID: 24041646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Ligand Efficacy of Cannabinoid Receptor 1 (CB1) using Molecular Dynamics Simulations.
    Jung SW; Cho AE; Yu W
    Sci Rep; 2018 Sep; 8(1):13787. PubMed ID: 30213978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of the human cannabinoid receptor coding region splice variants (hCB₁) affects the function of hCB₁ receptor complexes.
    Bagher AM; Laprairie RB; Kelly ME; Denovan-Wright EM
    Eur J Pharmacol; 2013 Dec; 721(1-3):341-54. PubMed ID: 24091169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the role of the CB1 toggle switch in interaction networks using molecular dynamics simulation.
    Ji S; Yang W; Yu W
    Sci Rep; 2021 Nov; 11(1):22369. PubMed ID: 34785728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of molecular signatures and molecular dynamics simulation of highly deleterious missense variants of key autophagy regulator beclin 1: a computational based approach.
    Kaur S; Vashistt J; Changotra H
    J Biomol Struct Dyn; 2024 Nov; 42(18):9691-9704. PubMed ID: 37640005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of Functional CB
    Fay JF; Farrens DL
    Methods Enzymol; 2017; 593():343-370. PubMed ID: 28750810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations.
    Scott CE; Abrol R; Ahn KH; Kendall DA; Goddard WA
    Protein Sci; 2013 Jan; 22(1):101-13. PubMed ID: 23184890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers.
    Reggio PH
    AAPS J; 2006 May; 8(2):E322-36. PubMed ID: 16796383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.